Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5725
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMirvosit M. Karimov , Pulat S. Zufarov , Guzal N. Sobirova, Shahlo S. Aripdjanova, Dildora K. Karimova-
dc.date.accessioned2023-01-10T06:58:25Z-
dc.date.available2023-01-10T06:58:25Z-
dc.date.issued2022-
dc.identifier.issn2181-1326-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/5725-
dc.description.abstractIt has been shown that in patients with GERD and functional dyspepsia, the use of proton pump inhibitors leads to a decrease in heartburn and pain behind the sternum. However, symptoms such as regurgitation, belching, feeling of early satiety and heaviness after eating were stopped ineffectively. The inclusion in the treatment complex of the prokinetic domperidone at a dose of 10 mg 3 times a day contributed to a more effective regression of symptoms of impaired motility of the esophagus and stomach.en_US
dc.language.isoenen_US
dc.publisherCentral Asian Journal of Medicineen_US
dc.subjectgastroesophageal reflux disease, functional dyspepsia, proton pump inhibitors, prokinetics.en_US
dc.titleОptimization of therapy for gastroesophageal reflux disease in comorbidity with functional dyspepsiaen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
17. Central As J of M 4,22_77-84.pdf1.17994.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.